Target
Vasopressin V2 receptor
Ligand
BDBM477637
Substrate
n/a
Meas. Tech.
Inhibition Activity Assay
IC50
59400±n/a nM
Citation
 Li, XHe, WWang, BZhang, ZHe, FTao, W Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine US Patent  US10889569 Publication Date 1/12/2021 
Target
Name:
Vasopressin V2 receptor
Synonyms:
ADHR | AVPR V2 | AVPR2 | Antidiuretic hormone receptor | DIR | DIR3 | Renal-type arginine vasopressin receptor | V2R | V2R_HUMAN | VASOPRESSIN V2 | Vasopressin V2 receptor | Vasopressin receptor
Type:
Receptor
Mol. Mass.:
40295.28
Organism:
Homo sapiens (Human)
Description:
P30518
Residue:
371
Sequence:
MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS
  
Inhibitor
Name:
BDBM477637
Synonyms:
7-Fluoro-4-(1-(5-(methoxymethyl)-4-(6-methoxypyridin-3-yl)-4H-1,2,4-triazol-3-yl) azetidin-3-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one 18 | US10889569, Example 18
Type:
Small organic molecule
Emp. Form.:
C21H21FN6O4
Mol. Mass.:
440.4276
SMILES:
COCc1nnc(N2CC(C2)N2C(=O)COc3cc(F)ccc23)n1-c1ccc(OC)nc1
Structure:
Search PDB for entries with ligand similarity: